DalsnaFinance

Los Angeles Physician Introduces Compounded Ketamine-Oxytocin Nasal Spray for Treatment-Resistant Depression and PTSD

Markets PR Newswire By PR Newswire 04 Jun 2026 16:02 1 min read
Los Angeles Physician Introduces Compounded Ketamine-Oxytocin Nasal Spray for Treatment-Resistant Depression and PTSD

NutraBrain Clinic, led by board-certified anesthesiologist Dr. David Mahjoubi, has introduced a compounded ketamine-oxytocin nasal spray prescribed via telehealth for patients with treatment-resistant depression, PTSD, and antidepressant-related emotional blunting. Available under...

NutraBrain Clinic, led by board-certified anesthesiologist Dr. David Mahjoubi, has introduced a compounded ketamine-oxytocin nasal spray prescribed via telehealth for patients with treatment-resistant depression, PTSD, and antidepressant-related emotional blunting. Available under...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.